A Hume Care membership is presented as a connected experience: an online assessment, clinician access, GLP-1 medication, a Hume Pod, an app and home delivery. For someone considering the service, however, the important question is not simply what comes in the package. It is who takes responsibility when an assessment becomes a prescription, a prescription becomes a pharmacy order, or a delivery problem becomes a clinical concern. Hume’s public terms divide those responsibilities among separate organizations.
This review follows that care pathway using public documentation consulted October 19, 2026. Hume documents an actual GLP-1 access program, but its pages leave consequential gaps around specific products, pharmacy identities, response times and the final price. They also disagree on state availability and money-back promises. The practical task is to reconcile those differences before paying, while distinguishing the platform’s advertised convenience from the independent clinical decisions and pharmacy services that treatment requires.
At a glance
- Who provides treatment
- Hume Health Care LLC describes itself as an administrative and technology platform; an independent clinical network handles evaluations, prescribing and ongoing clinical management.Sources: [4]
- Advertised starting price
- The homepage advertises a three-month plan starting at $199/month with a $100 welcome credit and also displays $299. The discount duration and effective three-month total are not established.Sources: [5]
- Pharmacy-dependent inclusion
- The self-pay membership includes consultations and medication when prescribed and fulfilled through Hume’s pharmacy partners; some medications, formulations or fulfillment options can cost extra.Sources: [4]
- Coverage discrepancy
- The coverage page lists Alabama, Arkansas, Louisiana and Mississippi as unavailable, while the homepage names only Louisiana and Mississippi.
- Cancellation deadline
- Cancellation must be completed through designated channels at least 48 hours before renewal. Canceling a prepaid term does not produce a prorated refund.Sources: [4]
Start by separating the platform from the medical practice
The legal counterparty is Hume Health Care LLC, a Delaware limited liability company. Its terms explicitly say Hume does not practice medicine, employ physicians, prescribe medications or dispense drugs. Instead, the company operates the technology and administrative platform. Evaluations, prescribing decisions and ongoing clinical management belong exclusively to an independent third-party clinical network. That distinction matters more than the homepage’s unified presentation of a physician-guided program: joining the platform is not the same event as receiving clinical approval.
Before accessing clinical services, users must separately accept the clinical network’s documents, which Hume links to MD Integrations. Those external documents were not reviewed here. Hume also points to a provider directory that it says includes legal names, license numbers, license types and states of licensure. The terms allow patients to review credentials and decline a particular provider without losing platform access. This review did not inspect that directory or independently verify professional licenses.
A prospective member should therefore establish both the administrative contact and the treating clinician’s identity. Ask which organization receives clinical messages, who can change a treatment plan and where the medical record is maintained. Our guide to the difference between a telehealth platform and its clinicians explains why those questions belong near the beginning of enrollment, rather than after a refill or service problem.
| Care step | Documented responsible party | What to confirm |
|---|---|---|
| Platform membership | Hume Health Care LLC | Billing interval, support route and renewal date |
| Evaluation and prescribing | Independent clinical network | Clinician identity and consultation process |
| Medication fulfillment | Dispensing pharmacy partner | Pharmacy name, exact product and additional charges |
| Delivery | Homepage advertises free next-day delivery | When the delivery clock starts and how problems are handled |
| Ongoing clinical management | Independent clinical network | Response expectations, refills and continuity arrangements |
The free assessment is only the first gate
Hume advertises a free online eligibility assessment that takes one minute. Its general access requirements are broader than that brief invitation suggests: users must be at least 18, live in a supported state, have a compatible device and reliable internet, and satisfy any additional eligibility requirements. Meeting those conditions does not guarantee clinical acceptance or a prescription. The terms reserve treatment suitability decisions to the independent clinical network’s physicians, exercising their own medical judgment.
The privacy policy describes a secondary eligibility screening for certain programs, including programs that may involve compounded medication. Questions may address prior GLP-1 use, documented qualifying conditions, allergies and intolerances. The reviewed documentation does not establish Hume’s complete clinical inclusion criteria, BMI thresholds, required laboratory testing or laboratory charges. Nor does it establish how quickly a clinical evaluation follows the initial assessment, or whether a particular consultation format is available.
Geography needs an explicit check. Services are limited to the United States and states where the network maintains licensed physician coverage. The dedicated coverage page lists Alaska and Hawaii as served, but identifies Alabama, Arkansas, Louisiana and Mississippi as unavailable. The homepage excludes only Louisiana and Mississippi. Residents should confirm their own state before paying; neither page should be treated as a guarantee that a particular medication or clinician will be available.
A GLP-1 program is not a verified product catalog
Hume’s terms describe two medication pathways. FDA-approved branded GLP-1 medications may be prescribed through the clinical network and filled by standard retail or mail-order pharmacies. Custom-compounded GLP-1 preparations may be prescribed and filled by compounding pharmacies. The reviewed pages do not establish a product-by-product catalog with medication names, concentrations, routes or presentations. A general GLP-1 reference therefore cannot tell a prospective patient exactly what would be prescribed, supplied or included at the advertised price.
For compounded preparations, Hume requires an independent physician determination that the formulation is appropriate to the person’s circumstances. The terms mention prior documented GLP-1 use or a qualifying condition as possible circumstances, not an exhaustive eligibility rule. Hume also disclaims any guarantee of a particular medication, prescription approval or pharmacy. Its homepage promotes glycine, B12 and B6 as built-in protocol components, but the documentation reviewed here does not verify the claimed muscle-protection or side-effect benefits.
FDA approval belongs to a specific product, not to Hume or its pharmacy partners. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; nonapproval alone does not prove clinical inequivalence. FDA recommends compounded drugs for patients whose medical needs cannot be met by an approved drug. Before accepting a proposed treatment, use a product, route and pharmacy check rather than relying on the ingredient family or program name.
The pharmacy handoff needs its own confirmation
Hume’s terms assign formulation, dispensing and fulfillment responsibilities to pharmacies, rather than the platform. Users are to receive a choice of pharmacy partners. If a selected pharmacy becomes unavailable, Hume may facilitate connection to another partner, but dispensing decisions remain with the pharmacy. No specific dispensing pharmacies or their accreditations were established in the reviewed documentation. Ask for the pharmacy’s identity and direct contact information before an order is finalized, not merely the name of the platform taking payment.
The homepage advertises free next-day delivery and says the three-month plan ships monthly to the member’s door. Those statements do not establish the time from assessment to approval, approval to dispensing, or dispensing to arrival. The public documentation also does not clarify next-day service conditions, cold-chain procedures or replacement arrangements for damaged or delayed deliveries. A three-month plan label, by itself, does not establish medication quantity, shipment contents or a minimum membership commitment.
For a practical handoff, request the exact product label, storage instructions, expected dispatch date and problem-resolution contact. Our pharmacy handoff questions can help organize that conversation. FDA specifically advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated, and contacting the provider or dispensing pharmacy. That is general FDA advice, not evidence of a delivery problem at Hume; its relevance is that the public pages leave the delivery-response process unclear.
Understand the payment before authorizing the care pathway
The homepage presents a physician-guided three-month plan starting at $199 per month, displays $299 alongside it and applies a $100 welcome credit. It does not establish how long the promotional price lasts or the effective total collected for that plan. The offer lists a medical consultation, one-to-one doctor support, Hume Pod, app and shipping as free. These are promotional inclusions, not enough information to establish the complete checkout charge, subsequent price or cost of every possible treatment.
The terms describe a self-pay flat membership covering platform access, clinical consultations and medication if prescribed and fulfilled through Hume’s pharmacy partners. That pharmacy-channel restriction matters. Certain medications, dosages, formulations or fulfillment options may carry additional charges disclosed at fulfillment. Billing intervals may be monthly, quarterly, semiannual or annual, with any prepaid total disclosed at checkout. These are possible plan structures, not proof that everyone must prepay three months. Obtain the chosen interval and total in writing.
Hume says it is not enrolled in Medicare, Medicaid or other government healthcare programs. Under the current flat-fee arrangement, members agree not to seek or accept reimbursement from health insurance or public programs, including TRICARE and Veterans Affairs benefits. Separately, the homepage advertises FSA/HSA reimbursement eligibility; that is not a promise of health-plan reimbursement or an individualized tax determination. Another unresolved issue is the contractual guarantee’s exclusion of clinical fees at enrollment and each refill, despite the promotion’s free-consultation language.
Connected tracking does not replace clinical follow-up
Hume advertises unlimited clinician access around the clock, side-effect support, continuous physician optimization, progress monitoring and post-medication guidance. Those features could make a connected program attractive, but the reviewed documents do not establish individual response times, appointment availability, escalation procedures or a refill schedule. Twenty-four-hour access should not be read as a promise of an immediate clinical answer. Ask what happens when a concern cannot wait for the usual messaging workflow and who follows up after a treatment change.
The homepage describes monthly body-composition scans, while other homepage language refers to weekly scans. More importantly, the terms restrict device data to informational, non-diagnostic context: clinicians may not rely on those data for diagnosis, prescribing or medication dosing. That boundary qualifies the marketing impression of treatment evolving with body measurements. A Hume Pod may be part of the experience, but the documentation does not support treating its readings as an independent clinical decision system.
NIDDK describes medication follow-up as a discussion of response and tolerability, not simply continued payments or measurements. Treatment duration depends on response and side effects, and post-medication guidance does not establish that weight loss will persist after stopping. For Hume, useful questions include how the network reviews symptoms, when reassessment occurs and what continuity looks like if medication or pharmacy availability changes. Our guide to what ongoing GLP-1 support means provides a framework for comparing those answers.
Know which data reach the care team
Hume’s privacy policy says Hume Care is not a HIPAA-covered entity. It describes adopting privacy and security practices that meet or exceed HIPAA standards as its own voluntary commitment. That statement should not be converted into a finding that every component of the service has the same legal status or protections. The platform, clinical network and pharmacy are separate parts of the experience, and the external clinical documents were not reviewed here.
The policy also says wellness data do not automatically flow from Hume Health into Hume Care. Sharing is user-initiated through account linking and permission settings. Members should understand which account holds which information and whether intended sharing has actually been enabled. Conversely, linking an account should not be mistaken for evidence that a clinician has reviewed every measurement. Device availability, data transmission and clinical review are different steps, especially given the contractual limits on using device data.
The policy’s description of Pro.f makes another useful distinction. It can help prepare for consultations, but does not diagnose, recommend treatment or dose changes, make autonomous clinical decisions, or send information directly to a provider’s clinical record on the user’s behalf. A member who prepares notes with that feature still needs to communicate concerns through the actual care channel. The reviewed pages also do not establish Spanish-language clinical service, interpretation or specific accessibility arrangements.
Plan the exit as carefully as the enrollment
Hume’s membership automatically renews at the then-current price. Prepaid members are promised an email reminder at least seven days before renewal. Although the homepage says cancellation is available anytime without fees, the terms require cancellation to be completed at least 48 hours before renewal through Account → Subscription in the web application or support@humecare.com. Canceling a prepaid plan preserves access through the paid term but does not produce a prorated refund; partially used membership periods are nonrefundable.
There is a separate initial-ineligibility provision: if the physician finds the person ineligible for any treatment after the initial evaluation, Hume says it will refund the membership fee within 10 business days of that determination. An included device must be returned in original condition; otherwise its cost can be deducted. That refund provision does not mean every denied medication triggers reimbursement, and the stated issuance period does not guarantee when a bank will make the funds available.
The guarantees require particular caution. The homepage promises 10% weight loss in six months or money back, but the contractual guarantee concerns no measurable loss during the initial 90 days. It excludes prior GLP-1 users and clinical consultation fees, requires 13 weekly Hume Pod weigh-ins, adherence to clinical recommendations and active paid membership. Claims must be submitted within 14 days after the period; verification may take two weeks, followed by a refund within 10 business days. Get the applicable promise clarified before relying on it.
Questions & answers
Does Hume itself prescribe the medication?
No. Its terms assign prescribing, evaluations and ongoing clinical management to an independent clinical network, not Hume Health Care LLC. Users must accept that network’s documents separately. Ask for the treating clinician’s identity and clinical contact route; the platform’s customer-support address should not be assumed to be the channel for medical decisions.
Can I count on paying $199 each month?
The documented offer is a starting price associated with a $100 welcome credit, not a verified permanent rate. The pages do not establish the discount duration, three-month checkout total or renewal amount. Terms also allow certain medication and fulfillment charges outside membership. Confirm the first charge, billing interval, subsequent charges and exact included product before authorizing payment.
Is Hume available in Alabama or Arkansas?
The dedicated coverage page lists both as unavailable, even though the homepage’s exclusion list names only Louisiana and Mississippi. That inconsistency requires direct confirmation rather than choosing the more favorable page. Hume’s terms limit service to states where its clinical network maintains licensed physician coverage, and availability can change.
Does next-day delivery mean treatment starts tomorrow?
No documented timeline supports that conclusion. Hume advertises free next-day delivery, but the reviewed pages do not establish assessment turnaround, prescribing time, pharmacy processing or the delivery promise’s operating conditions. Ask when the shipping clock starts, who provides tracking and which organization handles a delay or a temperature concern.
Will the Hume Pod automatically guide my prescription?
The terms say device data are informational only and cannot be relied upon for diagnosis, prescribing or dosing. Data sharing from Hume Health to Hume Care also requires user-initiated linking and permissions. Ask how measurements are reviewed, but do not interpret app connectivity or body-composition tracking as an automated prescribing service.
Can I cancel and use the money-back guarantee?
Those are different processes. Cancellation stops future renewal when completed at least 48 hours beforehand, but does not refund a partially used prepaid term. The contractual guarantee requires remaining an active paying member through its period and satisfying other conditions. Because its terms differ from the homepage promise, obtain written clarification before assuming cancellation preserves a guarantee claim.
Our assessment
Hume documents a potentially convenient model: a platform membership connecting independent clinical care, pharmacy fulfillment, tracking tools and advertised ongoing support. Its terms usefully distinguish those responsibilities and preserve physician judgment rather than promising a prescription. The unresolved issues are material, however: exact products and pharmacies, response and delivery procedures, complete charges, conflicting state lists and incompatible guarantee language. For a prospective member, the strongest preparation is a written confirmation of the clinician, pharmacy, product, payment schedule and problem-resolution process before enrollment. The connected presentation is a reason to examine those handoffs closely, not evidence that every handoff is already seamless.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.